Compare DexCom, Inc. (DXCM) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Tenet Healthcare Corporation — how do they compare? DexCom, Inc. trades at $77.28 (market cap $28.06B), while Tenet Healthcare Corporation trades at $197.77 (market cap $16.57B). The key difference: DexCom, Inc. is the larger of the two by market cap, and DexCom, Inc. is trading nearer its 52-week high, Tenet Healthcare Corporation nearer its low. Which is the better fit depends on your goals.
| DXCM | THC | |
|---|---|---|
Market Cap | $28.06B | $16.57B |
Sector | Health | Health |
52-Week High | $89.53 | $244.80 |
52-Week Low | $54.84 | $148.38 |
Enterprise Value | $27.03B | $26.81B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Tenet Healthcare (THC) trades at $198.46, up 8.04% in the last 24 hours, showing strong momentum. The stock is supported by a bullish analyst consensus with a $235.88 price target, while recent earnings have consistently beaten expectations. However, technical indicators signal a bearish short-term trend, with the price currently testing key support levels near $191.
The outlook is positive based on solid fundamentals, including a low P/E of 10 and strong profitability metrics like a 37.87% ROE. Key risks include market volatility ahead of Q2 2026 earnings on July 24 and potential macroeconomic pressures on the healthcare sector. The primary opportunity lies in the stock's attractive valuation relative to its growth and analyst targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
